The weekly litigation news digest is live. Subscribe now

IP Verse

Treatment Comprising Oral Or Gastric Administration Of Edaravone - EP3551181

The patent EP3551181 was granted to Treeway TW on Nov 18, 2020. The application was originally filed on Jan 17, 2018 under application number EP18701303A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3551181

TREEWAY TW
Application Number
EP18701303A
Filing Date
Jan 17, 2018
Status
Opposition Rejected
Nov 10, 2023
Publication Date
Nov 18, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BARDEHLE PAGENBERG PARTNERSCHAFT MBB PATENTANWALTEAug 18, 2021BARDEHLE PAGENBERG PARTNERSCHAFT MBB PATENTANWALTE RECHTSANWALTE -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONCN101953832
DESCRIPTIONCN105816423
DESCRIPTIONEP1405637
DESCRIPTIONEP1714960
DESCRIPTIONEP2754440
DESCRIPTIONWO2012019381
INTERNATIONAL-SEARCH-REPORTCN102349893
OPPOSITIONCN102349893
OPPOSITIONEP1714960
OPPOSITIONJP2004002400
OPPOSITIONJP2009143922
OPPOSITIONJP2009155315
OPPOSITIONJP2009280561
OPPOSITIONJP2010077104

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents